Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam dose comparison with alfentanil during ERCP induction in elderly patients
ChiCTR2400090855Phase 4Not yet recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam and alfentanil in biliary disease (3 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Mean arterial pressure. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
remimazolamalfentanil
03
Conditions
biliary disease
Beyond the preview
Go deeper on ChiCTR2400090855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090855.